Histamine is involved in ultraviolet B-induced pigmentation of guinea pig skin.
We previously reported that histamine induced melanogenesis in cultured human melanocytes and that the stimulatory effect was mediated by protein kinase A activation via H2 receptors. It is well-known that ultraviolet B irradiation causes acute inflammation, known as erythema, and subsequent pigmentation, and there are several reports demonstrating an elevation of the histamine levels in ultraviolet B-irradiated skin. Thus, to evaluate the involvement of histamine in ultraviolet B-induced skin pigmentation, we examined the effect of an H2 antagonist in brownish guinea pig skin. Daily exposure to 200 mJ per cm2 ultraviolet B for 3 d evoked erythema and subsequent pigmentation in the skin samples tested. Moreover, a remarkable increase in dopa-positive melanocytes was observed in the pigmented area, which showed an increase in melanin synthesis. Topical application of famotidine, an H2 antagonist, significantly reduced pigmentation and moderated the increase of dopa-positive melanocytes in the ultraviolet B-irradiated skin. Even when the initiation of famotidine application was delayed to day 2 after irradiation, an inhibitory activity on ultraviolet B-induced pigmentation was observed; however, the ultraviolet B-induced erythema was not suppressed by topically applied famotidine. Thus, we concluded that histamine is involved in ultraviolet B-induced pigmentation and that famotidine suppressed the pigmentation by the prevention of histamine binding to H2 receptors in melanocytes but not by prevention of ultraviolet B permeability and inflammation.
Yoshida
Masaki
M
Basic Research Laboratory, Kanebo Ltd, Kotobuki-cho, Odawara-shi, Kanagawa-ken, Japan. myos@oda.cos.kanebo.co.jp
Hirotsu
Sachiyo
S
Nakahara
Michio
M
Uchiwa
Hideyo
H
Tomita
Yasushi
Y
D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D004334:Drug Administration Schedule; D004890:Erythema / Q000517:prevention & control; D015738:Famotidine / Q000008:administration & dosage / Q000494:pharmacology; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology / Q000502:physiology*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D008544:Melanocytes / Q000187:drug effects / Q000528:radiation effects; D011832:Radiation Injuries / Q000517:prevention & control; D011899:Ranitidine / Q000494:pharmacology; D012880:Skin Pigmentation / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects*; D014466:Ultraviolet Rays
D006635:Histamine H2 Antagonists; D015738:Famotidine; D006632:Histamine; D011899:Ranitidine